Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
2021
Abstract. We describe a 79-year-old man with spondylodiscitis and unknown
pathogen, treated with cefazolin and rifampicin. He developed a massive
digestive hemorrhage. Prothrombin time was prolonged with severe
vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur
during cefazolin and rifampicin use. This deficiency should be assessed
before prescribing cefazolin–rifampicin and prothrombin time monitored.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
11
References
0
Citations
NaN
KQI